Prognostic correlates of combined coronary flow reserve assessment on left anterior descending and right coronary artery in patients with negative stress echocardiography by wall motion criteria

Heart

Volumn 95, Issue 17, 2009, Pages 1423-1428

  Cortigiani, L ^a   Rigo, F ^b   Sicari, Rosa ^c   Gherardi, S ^d   Bovenzi, F ^a   Picano, E ^d  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b Ospedale Umberto I   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d Cesena Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY FLOW RESERVE; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RIGHT CORONARY ARTERY; STRESS ECHOCARDIOGRAPHY;

AGED; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; VASODILATOR AGENTS;

EID: 69249117029     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.166439     Document Type: Article

References (46)

1. Rigo F. Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 2005;3:8
2. Rigo F, Richieri M, Pasanisi E, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 2003;91:269-73.
3. Nohtomi Y, Takeuchi M, Nagasawa K, et al. Simultaneous assessment of wall motion and coronary flow velocity in the left anterior descending coronary artery during dipyridamole stress echocardiography. J Am Soc Echocardiogr 2003;16:457-63.
4. Lowenstein J, Tiano C, Marquez G, et al. Simultaneous analysis of wall motion and coronary flow reserve of the left anterior descending coronary artery by transthoracic Doppler echocardiography during dipyridamole stress echocardiography. J Am Soc Echocardiogr 2003;16:607-13.
5. Chirillo F, Bruni A, De Leo A, et al. Usefulness of dipyridamole stress echocardiography for predicting graft patency after coronary artery bypass grafting. Am J Cardiol 2004;93:24-30.
6. Ascione L, De Michele M, Accadia M, et al. Incremental diagnostic value of ultrasonographic assessment of coronary flow reserve with high-dose dipyridamole in patients with acute coronary syndrome. Int J Cardiol 2006;106:313-8.
7. Rigo F, Murer B, Ossena G, et al. Transthoracic echocardiographic imaging of coronary arteries: tips, traps, and pitfalls. Cardiovasc Ultrasound 2008;6:7
8. Takeuchi M, Ogawa K, Wake R, et al. Measurement of coronary flow velocity reserve in the posterior descending coronary artery by contrast-enhanced transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2004;17:21-7.
9. Rigo F, Sicari R, Gherardi S, et al. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. Eur Heart J 2008;29:79-88.
10. Rigo F, Cortigiani L, Pasanisi E, et al. The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A transthoracic vasodilator stress echo study. Am Heart J 2005;149:684-9.
11. Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007;50:1354-61.
12. Rigo F, Sicari R, Gherardi S, et al. Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter. Am J Cardiol 2007;100:1527-31.
13. Rigo F, Gherardi S, Galderisi M, et al. The prognostic impact of coronary flow reserve assessed by Doppler echocardiography in non-ischemic dilated cardiomyopathy. Eur Heart J 2006;27:1319-23.
14. Rigo F, Gherardi S, Galderisi M, et al. The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2007;99:1154-8.
15. Cortigiani L, Rigo F, Gherardi S, et al. Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol 2008;102:1718- 23.
16. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2. Geneva: WHO, 1999.
17. European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
18. National Cholesterol Education Program Expert Panel. Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Full Report. www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf, 2001.
19. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement from the European Association of Echocardiography. Eur J Echocardiogr 2008;9:415-37.
20. Lang RM, Bierig M, Devereux RB, et al, Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
21. Picano E, Landi P, Bolognese L, et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large scale multicenter trial. Am J Med 1993;11:608-18.
22. Gottdiener JS, Bednarz J, Devereux R, et al, American Society of Echocardiography. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004;17:1086-119.
23. Lauer MS, Blackstone EH, Young JB, et al. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618-20.
24. Gibler WB, Cannon CP, Blomkalns AL, et al, American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, Society of Chest Pain Centers. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. Circulation 2005;111:2699-771.
25. Picano E, Palinkas A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 2001;19:1177-83.
26. Galderisi M, de Simone G, Cicala S, et al. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 2003;21:2183-8
27. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991;83:1256-62.
28. San Roman JA, Vilacosta I, Castillo JA, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 1996;110:1248-54.
29. Ferrara N, Coltorti F, Leosco D, et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate. Eur Heart J 1995;16:903-8.
30. Longobardi G, Ferrara N, Leosco D, et al. Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity. J Cardiovasc Pharmacol 2000;36:50-5.
31. Palinkas A, Toth E, Amyot R, et al. The value of ECG and echocardiography during stress testing for identifying systemic endothelial dysfunction and epicardial artery stenosis. Eur Heart J 2002;23:1587-95.
32. Rigo F, Pratali L, Palinkas A, et al. Coronary flow reserve and brachial artery reactivity in patients with chest pain and "false positive" exercise-induced ST-segment depression. Am J Cardiol 2002;89:1141-4.
33. Di Carli MF, Janisse J, Grunberger G, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 1997;30:1472-7.
34. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 2005;109:143-59.
35. Takahashi T, Hiasa Y, Ohara Y, et al. Acute hyperglycaemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction. Heart 2008;94:1402-6.
36. Van Herck PL, Carlier SG, Claeys MJ, et al. Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure. Heart 2007;93:1231- 7.
37. Sicari R, Cortigiani L, Bigi R, et al. Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing. Circulation 2004;109:2428-31.
38. Cortigiani L, Bigi R, Sicari R, et al. Comparison of prognostic value of pharmacologic stress echocardiography in chest pain patients with versus without diabetes mellitus and positive exercise electrocardiography. Am J Cardiol 2007;100:1749-9.
39. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
40. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
41. Albertal M, Voskuil M, Piek JJ, et al, Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation 2002;105:1573-8.
42. L'Abbate. Large and micro coronary vascular involvement in diabetes. Pharmacol Rep 2005;57(suppl):3-9
43. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-40
44. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
45. Picano E, Molinaro S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound 2008;6:30
46. Picano E. Stress echocardiography. 5th ed. Berlin: Springer.